BRIGHTHOUSE FINANCIAL INC (BHF)

US10922N1037 - Common Stock

48.99  +0.49 (+1.01%)

After market: 48.99 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BHF. BHF was compared to 141 industry peers in the Insurance industry. Both the profitability and financial health of BHF have multiple concerns. BHF is not valued too expensively and it also shows a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year BHF was profitable.
BHF had a negative operating cash flow in the past year.
In the past 5 years BHF always reported negative net income.
In multiple years BHF reported negative operating cash flow during the last 5 years.

1.2 Ratios

BHF has a Return On Assets of -0.51%. This is in the lower half of the industry: BHF underperforms 77.86% of its industry peers.
BHF's Return On Equity of -24.56% is on the low side compared to the rest of the industry. BHF is outperformed by 88.57% of its industry peers.
Industry RankSector Rank
ROA -0.51%
ROE -24.56%
ROIC N/A
ROA(3y)-0.21%
ROA(5y)-0.28%
ROE(3y)-9.19%
ROE(5y)-7.68%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BHF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BHF has less shares outstanding
The number of shares outstanding for BHF has been reduced compared to 5 years ago.
The debt/assets ratio for BHF has been reduced compared to a year ago.

2.2 Solvency

A Debt/Equity ratio of 0.64 indicates that BHF is somewhat dependend on debt financing.
BHF has a worse Debt to Equity ratio (0.64) than 73.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.66% over the past year.
BHF shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.38% yearly.
BHF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.77%.
The Revenue for BHF have been decreasing by -14.41% on average. This is quite bad
EPS 1Y (TTM)55.66%
EPS 3YN/A
EPS 5Y13.38%
EPS growth Q2Q-21.1%
Revenue 1Y (TTM)-44.77%
Revenue growth 3Y-21.48%
Revenue growth 5Y-14.41%
Revenue growth Q2Q208.37%

3.2 Future

Based on estimates for the next years, BHF will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.42% on average per year.
BHF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y25.62%
EPS Next 2Y19.19%
EPS Next 3Y17.42%
EPS Next 5YN/A
Revenue Next Year4.09%
Revenue Next 2Y3.02%
Revenue Next 3Y1.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.52, the valuation of BHF can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of BHF indicates a rather cheap valuation: BHF is cheaper than 84.29% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.28. BHF is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 2.81, the valuation of BHF can be described as very cheap.
Based on the Price/Forward Earnings ratio, BHF is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
BHF is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.52
Fwd PE 2.81

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BHF's earnings are expected to grow with 17.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)0.26
EPS Next 2Y19.19%
EPS Next 3Y17.42%

0

5. Dividend

5.1 Amount

No dividends for BHF!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTHOUSE FINANCIAL INC

NASDAQ:BHF (5/3/2024, 7:00:01 PM)

After market: 48.99 0 (0%)

48.99

+0.49 (+1.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.06B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 3.52
Fwd PE 2.81
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.14
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA -0.51%
ROE -24.56%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)55.66%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y25.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-44.77%
Revenue growth 3Y-21.48%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y